Cryopreservation medium for primate embryo stem cells and cryopreservation method

• US 20050026133A1
• Filed: 07/30/2004
• Published: 02/03/2005
• Est. Priority Date: 01/31/2002
• Status: Abandoned Application

• Current Assignee: Asahi Techno Glass Corp (AGC, Inc.)
• Original Assignee: Asahi Techno Glass Corp (AGC, Inc.)
• Inventors: Nakatsuji, Norio, Suemori, Hirofumi, Asaka, Isao
• Application Number:
  US10/902,571
• Publication Number:
  US 20050026133A1
• Time in Patent Office: Days
• US Class Current: 435/2
• CPC Class Codes: A01N 1/02 Preservation of living parts
• CPC Class Codes: A01N 1/0221 Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
• CPC Class Codes: C12N 5/0606 Pluripotent embryonic cells, e.g. embryonic stem cells [ES] embryonic germ cells C12N5/0611, induced pluripotent stem cells C12N5/0696

Abstract

A cryopreservation medium and a cryopreservation method which make it possible to cryopreserve ES cells from primates simply with high viability are provided. A cryopreservation medium containing a cryoprotectant at a Concentration of from 12% (W/V) to 50% (W/V) and a cryopreservation method for primate embryonic stem cells, which comprises a step of suspending primate embryonic stem cells in the cryopreservation medium, and a refrigeration step of freezing the suspension of the primate embryonic stem cells in the cryopreservation medium by cooling it to −80° C. or below at a rate of from 0.5° C. to 10° C. per minute, and a preservation step of storing the frozen suspension of primate embryonic stem cells in the cryopreservation medium enable simple cryopreservation of primate embryonic stem cells with high viability.

Claims

1. A cryopreservation medium for primate embryonic stem cells containing a cryoprotectant at a concentration of from 12% (W/V) to 50% (W/V).

2. The cryopreservation medium according to claim 1, wherein the concentration of the cryoprotectant is from 15% (W/V) to 30% (W/V).

3. The cryopreservation medium according to claim 1, which contains at least one component selected from the group consisting of dimethyl sulfoxide, glycerin, ethylene glycol, propylene glycol and polyvinyl pyrrolidone as the cryoprotectant.

4. The cryopreservation medium according to claim 1, wherein the cryoprotectant is dimethyl sulfoxide and/or glycerin.

5. The cryopreservation medium according to claim 4, wherein the cryoprotectant is dimethyl sulfoxide, and its concentration is from 15% (W/V) to 30% (W/V).

6. The cryopreservation medium according to claim 4, wherein the cryoprotectant is glycerin, and its concentration is from 12% (W/V) to 30% (W/V).

7. The cryopreservation medium according to claim 1, which contains, in addition to the cryoprotectant, serum and/or a serum replacement at a concentration of from 10% (W/V) to 85% (W/V).

8. The cryopreservation medium according to claim 1, which contains, in addition to the cryoprotectant, serum at a concentration of from 10% (W/V) to 50% (W/V).

9. The cryopreservation medium according to claim 7, wherein the serum is fatal bovine serum.

10. The cryopreservation medium according to claim 7, wherein the serum replacement contains at least one component selected from the group consisting of albumin or albumin substitutes, transferrin or transferrin substitutes, and insulin or insulin substitutes.

11. The cryopreservation medium according to claim 7, wherein the serum replacement contains at least one component selected from the group consisting of albumin or albumin substitutes, transferrin or transferrin substitutes, and insulin or insulin substitutes and at least one component selected from the group consisting of amino acids, vitamins, antioxidants, collagen precursors and trace elements.

12. The cryopreservation medium according to claim 7, which contains, in addition to the cryoprotectant and serum and/a serum replacement, a basal medium for animal tissue culture containing at least from 0.3% (W/V) to 5% (W/V) of glucose, at a concentration of from 10% (W/V) to 75% (W/V).

13. A cryopreservation method for primate embryonic stem cells using the cryopreservation medium as defined in claim 1, which comprises a step of suspending primate embryonic stem cells in the cryopreservation medium, and a refrigeration step of freezing the suspension of the primate embryonic stem cells in the cryopreservation medium by cooling it to −

80°

C. or below, and a preservation step of storing the frozen suspension of primate embryonic stern cells in the cryopreservation medium.

14. The cryopreservation method according to claim 13, wherein the cooling rate in the refrigeration step of freezing the suspension of the primate embryonic stem cells in the cryopreservation medium by cooling it to −

80°

C. or below is from 0.5°

C. to 10°

C. per minute.